K-lyte/cl 50

  • Electrolyte disturbances

K-lyte/cl 50 Generic Name & Formulations

General Description

Potassium (as chloride) 50mEq; effervescent tabs for soln; citrus and fruit-flavor.

See Also

How Supplied

K-Lyte/Cl tabs—30, 100, 250; K-Lyte/Cl 50 tabs—30, 100


K-lyte/cl 50 Indications


Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.

K-lyte/cl 50 Dosage and Administration


Prophylaxis: 25mEq daily. Treatment: 50–100mEq daily in divided doses. Both, dissolve each tab in 6–8oz of water and sip slowly over 5–10 minutes after meals.


Not recommended.

K-lyte/cl 50 Contraindications


Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility.

K-lyte/cl 50 Boxed Warnings

Not Applicable

K-lyte/cl 50 Warnings/Precautions


Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.

K-lyte/cl 50 Pharmacokinetics

See Literature

K-lyte/cl 50 Interactions


Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.

K-lyte/cl 50 Adverse Reactions

Adverse Reactions

Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation.

K-lyte/cl 50 Clinical Trials

See Literature

K-lyte/cl 50 Note

Not Applicable

K-lyte/cl 50 Patient Counseling

See Literature